AliveDx Submits FDA 510(k) for MosaiQ AiPlex® Vasculitis Assay to Advance Autoimmune Diagnostics
AliveDx, a global in-vitro diagnostics innovator, today announced it has submitted a 510(k) premarket notification to the U.S. Food...
Multiplex Assays
Advertisement
Advertisement
